4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-23-013004
President and CEO sold 27,750 shares at an average $24.53 ($680,747)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SCANGOS GEORGE A President and CEO | 2023-02-23 | Sale | −12,631 | $25.97 | $328,065 | 183,608 | D: show line 1 in the form |
| SCANGOS GEORGE A President and CEO | 2023-02-24 | Sale | −4,239 | $22.74 | $96,382 | 179,369 | D: show line 2 in the form |
| SCANGOS GEORGE A President and CEO | 2023-02-24 | Sale | −10,880 | $23.56 | $256,300 | 168,489 | D: show line 3 in the form |
| Open-market sales · 27,750 sh · avg $24.53 · $680,747 | |||||||
Loading xslF345X03/doc4.xml…